References
Riek R, Eisenberg D (2016) The activities of amyloids from a structural perspective. Nature 539:227–235. https://doi.org/10.1038/nature20416
Benson M, Buxbaum J, Eisenberg D, Merlini G, Saraiva M, Sekijima Y, Sipe J, Westermark P (2020) Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 27(4):217–222. https://doi.org/10.1080/13506129.2020.1835263
Milani P, Basset M, Russo F, Foli A, Palladini G, Merlini G (2017) The lung in amyloidosis. Eur Respir Rev 26:170046. https://doi.org/10.1183/16000617.0046-2017
Arrossi A, Merzianu M, Farver C, Yuan C, Wang S, Nakashima M, Cotta C (2016) Nodular pulmonary light chain deposition disease: an entity associated with Sjogren syndrome or marginal zone lymphoma. J Clin Pathol 69:490–496. https://doi.org/10.1136/jclinpath-2015-203342
Bhargava P, Rushin J, Rusnock E, Hefter L, Franks T, Sabnis S, Travis W (2007) Pulmonary light chain deposition disease: report of five cases and review of the literature. Am J Surg Pathol 31(2):267–276. https://doi.org/10.1097/01.pas.0000213358.18380.d2
Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, Dogan A (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114(24):4957–4959. https://doi.org/10.1182/blood-2009-07-230722
Stokes M, Jagirdar J, Burchstin O, Kornacki S, Kumar A, Gallo G (1997) Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod Pathol 10:1059–1065
Li H, Lu Y (2021) Pulmonary amyloidosis and cystic lung disease in primary Sjogren’s syndrome: a case report and literature review. Clin Rheumatol 40(8):3345–3350. https://doi.org/10.1007/s10067-021-05596-9
Takahashi K, Sadamatsu H, Ogusu S, Komiya K, Nakamura T, Kimura S, Sueoka-Aragane N (2018) Sjogren syndrome complicated with cystic lung disease and pulmonary amyloidosis. Case Rep Rheumatol 2018:7475242. https://doi.org/10.1155/2018/7475242
Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev 25(140):110–123. https://doi.org/10.1183/16000617.0011-2016
Author information
Authors and Affiliations
Contributions
All authors contributed to the writing and editing/formatting of the manuscript.
Derald Charles: writing and editing of the manuscript
Elizabeth Pavlisko: writing and editing of the manuscript
Jadee Neff: writing and editing of the manuscript
Yubin Kang: writing and editing of the manuscript
John Carney: writing and editing of the manuscript
Corresponding author
Ethics declarations
Ethical approval
The current study was submitted and approved by the Duke Institutional Review Board for Clinical Investigations.
Consent to participate
The patient provided written informed consent for the publication of this case study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Charles, D.D., Pavlisko, E.N., Neff, J.L. et al. Coinciding kappa AL amyloidosis and kappa light chain deposition disease in the lung. Virchows Arch 483, 705–707 (2023). https://doi.org/10.1007/s00428-023-03610-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-023-03610-w